Palivizumab

Tax included
Palivizumab (MEDI 493), a humanized respiratory syncytial virus monoclonal antibody, reduces respiratory syncytial virus (RSV) infection.
MedChemExpress 
HY-P9944

Data sheet

Size
Multiple sizes
Reactivity
RSV
Application
COVID-19-anti-virus
CAS
188039-54-5